Literature DB >> 11111075

Biochemical and genetic aspects of mevalonate kinase and its deficiency.

S M Houten1, R J Wanders, H R Waterham.   

Abstract

Mevalonate kinase (MK) is an essential enzyme in the mevalonate pathway which produces numerous cellular isoprenoids. The enzyme has been characterized both at the biochemical and the molecular level in a variety of organisms. Despite the fact that mevalonate kinase is not the rate-limiting enzyme in isoprenoid biosynthesis, its activity is subject to feedback regulation by the branch-point intermediates geranyldiphosphate, farnesyldiphosphate and geranylgeranyldiphosphate. Recently, the importance of mevalonate kinase was demonstrated by the identification of its deficiency as the biochemical and molecular cause of the inherited human disorders mevalonic aciduria and hyperimmunoglobulinemia D and periodic fever syndrome. The pathophysiology of these disorders is not yet understood, but eventually will give insight into the in vivo role of mevalonate kinase and isoprenoid biosynthesis with respect to the acute phase response and fever. The subcellular localization of mevalonate kinase is still a matter of debate. The enzyme could be localized predominantly in the cytosol, or in peroxisomes, or it is associated differentially with peroxisomes. Here we review the biochemical and molecular properties of MK, and discuss its biological significance, the regulation of its enzyme activity and finally its subcellular localization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111075     DOI: 10.1016/s1388-1981(00)00135-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Computational model for monitoring cholesterol metabolism.

Authors:  R Selvakumar; M Rashith Muhammad; G Poornima Devi
Journal:  Syst Synth Biol       Date:  2014-08-01

2.  Recurrent fevers and failure to thrive in an infant.

Authors:  David R Scott; Sarah Chan; Johanna Chang; Lori Broderick; Hal M Hoffman
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

3.  Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency.

Authors:  Annalisa Marcuzzi; Giuliana Decorti; Alessandra Pontillo; Alessandro Ventura; Alberto Tommasini
Journal:  Inflamm Res       Date:  2010-02-21       Impact factor: 4.575

Review 4.  The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.

Authors:  Luca Cantarini; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Luisa Costa; Giacomo Emmi; Elena Silvestri; Flora Magnotti; Maria Cristina Maggio; Eugenia Prinzi; Giuseppe Lopalco; Bruno Frediani; Rolando Cimaz; Mauro Galeazzi; Donato Rigante
Journal:  Clin Rheumatol       Date:  2014-06-24       Impact factor: 2.980

5.  Intermittent neutropenia as an early feature of mild mevalonate kinase deficiency.

Authors:  Nima Parvaneh; Vahid Ziaee; Mohammad-Hassan Moradinejad; Isabelle Touitou
Journal:  J Clin Immunol       Date:  2013-11-01       Impact factor: 8.317

6.  Hyper-IgD and periodic fever syndrome (HIDS) due to compound heterozygosity for G336S and V377I in a 44-year-old patient with a 27-year history of fever.

Authors:  Stefan Schlabe; Carolynne Schwarze-Zander; Peter Lohse; Jürgen Kurt Rockstroh
Journal:  BMJ Case Rep       Date:  2016-11-29

Review 7.  Hyperimmunoglobulin D syndrome in childhood.

Authors:  Jeroen C H van der Hilst; Joost Frenkel
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

8.  Detection of a novel missense mutation in the mevalonate kinase gene in one Chinese family with DSAP.

Authors:  Wen-Sheng Lu; Xiao-Dong Zheng; Xiu-Hua Yao; Lan-Fang Zhang; Bai Hu; Yao-Juan Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Staphylococcus aureus mevalonate kinase: isolation and characterization of an enzyme of the isoprenoid biosynthetic pathway.

Authors:  Natalya E Voynova; Sandra E Rios; Henry M Miziorko
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

10.  Enterococcus faecalis mevalonate kinase.

Authors:  Matija Hedl; Victor W Rodwell
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.